JP4651282B2 - 造血幹細胞及び造血前駆細胞の増幅方法 - Google Patents

造血幹細胞及び造血前駆細胞の増幅方法 Download PDF

Info

Publication number
JP4651282B2
JP4651282B2 JP2004013291A JP2004013291A JP4651282B2 JP 4651282 B2 JP4651282 B2 JP 4651282B2 JP 2004013291 A JP2004013291 A JP 2004013291A JP 2004013291 A JP2004013291 A JP 2004013291A JP 4651282 B2 JP4651282 B2 JP 4651282B2
Authority
JP
Japan
Prior art keywords
cells
serum
hematopoietic
hematopoietic stem
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004013291A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005204539A (ja
JP2005204539A5 (enExample
Inventor
麻子 初山
仁也 伊藤
龍俊 中畑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Foundation for Biomedical Research and Innovation at Kobe
Original Assignee
Mitsubishi Tanabe Pharma Corp
Foundation for Biomedical Research and Innovation at Kobe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp, Foundation for Biomedical Research and Innovation at Kobe filed Critical Mitsubishi Tanabe Pharma Corp
Priority to JP2004013291A priority Critical patent/JP4651282B2/ja
Priority to US10/587,014 priority patent/US8168429B2/en
Priority to CA2554192A priority patent/CA2554192C/en
Priority to PCT/JP2004/010677 priority patent/WO2005071064A1/ja
Publication of JP2005204539A publication Critical patent/JP2005204539A/ja
Publication of JP2005204539A5 publication Critical patent/JP2005204539A5/ja
Application granted granted Critical
Publication of JP4651282B2 publication Critical patent/JP4651282B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2004013291A 2004-01-21 2004-01-21 造血幹細胞及び造血前駆細胞の増幅方法 Expired - Fee Related JP4651282B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2004013291A JP4651282B2 (ja) 2004-01-21 2004-01-21 造血幹細胞及び造血前駆細胞の増幅方法
US10/587,014 US8168429B2 (en) 2004-01-21 2004-07-21 Method of amplifying hematopoietic stem cell and hematopoietic progenitor cell
CA2554192A CA2554192C (en) 2004-01-21 2004-07-21 Method of amplifying hematopoietic stem cell and hematopoietic progenitor cell
PCT/JP2004/010677 WO2005071064A1 (ja) 2004-01-21 2004-07-21 造血幹細胞及び造血前駆細胞の増幅方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004013291A JP4651282B2 (ja) 2004-01-21 2004-01-21 造血幹細胞及び造血前駆細胞の増幅方法

Publications (3)

Publication Number Publication Date
JP2005204539A JP2005204539A (ja) 2005-08-04
JP2005204539A5 JP2005204539A5 (enExample) 2007-03-08
JP4651282B2 true JP4651282B2 (ja) 2011-03-16

Family

ID=34805380

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004013291A Expired - Fee Related JP4651282B2 (ja) 2004-01-21 2004-01-21 造血幹細胞及び造血前駆細胞の増幅方法

Country Status (4)

Country Link
US (1) US8168429B2 (enExample)
JP (1) JP4651282B2 (enExample)
CA (1) CA2554192C (enExample)
WO (1) WO2005071064A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200530269A (en) 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
JP4921083B2 (ja) * 2005-09-13 2012-04-18 タカラバイオ株式会社 レトロウィルス産生用無血清培地
RU2009100930A (ru) * 2006-06-14 2010-07-20 Чугаи Сейяку Кабусики Кайся (Jp) Лекарственные средства для стимуляции роста гемопоэтических стволовых клеток
WO2008009642A1 (en) * 2006-07-17 2008-01-24 Novozymes A/S Cell culture media
PL2194121T3 (pl) 2007-09-11 2017-02-28 Sapporo Medical University Sposób hodowania komórek i preparat farmaceutyczny do naprawy i regeneracji tkanek
US9527828B2 (en) 2007-12-06 2016-12-27 Nissan Chemical Industries, Ltd. Method for expanding hematopoietic stem cells using heterocyclic compound
JP5660451B2 (ja) 2008-03-11 2015-01-28 独立行政法人理化学研究所 造血幹/前駆細胞の特性を有する細胞の製造方法
CN102448949B (zh) * 2009-06-04 2014-09-03 日产化学工业株式会社 杂环化合物及造血干细胞的扩增剂
US9315776B2 (en) 2011-11-09 2016-04-19 National University Of Singapore Wharton's jelly mesenchymal stem cells and uses thereof
SG11201501024QA (en) 2012-08-15 2015-03-30 Univ Singapore Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells
US9402388B2 (en) * 2012-11-01 2016-08-02 National University Of Singapore Methods of freezing stem cells
JP2017532325A (ja) * 2014-10-03 2017-11-02 イエール ユニバーシティ 抗癌療法のための自然免疫系の改変
TWI548748B (zh) * 2015-04-16 2016-09-11 台灣尖端先進生技醫藥股份有限公司 造血幹/先驅細胞之體外放大培養方法及其立即可使用之組成物
TWI645039B (zh) * 2016-12-11 2018-12-21 生寶生物科技股份有限公司 無血清培養基及擴增造血幹細胞的方法
CN114686432B (zh) * 2020-12-28 2024-02-02 苏州方舟生物科技有限公司 一种中性粒细胞的高效扩增培养体系及其应用
US20240287458A1 (en) * 2021-06-30 2024-08-29 Regrow Biosciences Private Limited Method of obtaining hsc population, t cell population and nk cell population and compositions thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US5437994A (en) * 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5635386A (en) * 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US6037174A (en) * 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
WO1995006112A1 (en) 1993-08-23 1995-03-02 Baxter International Inc. In vitro growth of neutrophil and megakaryocyte precursors in serum-free media
US5505908A (en) 1994-09-01 1996-04-09 Halozone Technologies, Inc. Recycling and recovery of methyl bromide fumigant
CA2248142A1 (en) * 1996-03-12 1997-09-18 Life Technologies, Inc. Hematopoietic cell culture nutrient supplement
ATE299030T1 (de) * 1996-07-10 2005-07-15 Meiji Dairies Corp Verwendung von proteinen aus der mk familie als hämatopoietischer faktor
WO1998006822A1 (fr) * 1996-08-08 1998-02-19 Yoshitomi Pharmaceutical Industries, Ltd. Milieu de culture et ses applications
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US7427603B2 (en) * 2002-09-26 2008-09-23 The Children's Medical Center Corporation Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
US20060073591A1 (en) * 2004-01-09 2006-04-06 Abitorabi M A Cell culture media

Also Published As

Publication number Publication date
CA2554192C (en) 2013-09-10
US20070166825A1 (en) 2007-07-19
CA2554192A1 (en) 2005-08-04
JP2005204539A (ja) 2005-08-04
US8168429B2 (en) 2012-05-01
WO2005071064A1 (ja) 2005-08-04

Similar Documents

Publication Publication Date Title
JP4651282B2 (ja) 造血幹細胞及び造血前駆細胞の増幅方法
KR102510368B1 (ko) 혈관 콜로니 형성 세포
CN102144028B (zh) 造血前体的扩增
US20190002828A1 (en) Methods for producing enucleated erythroid cells derived from pluripotent stem cells
JP7779519B2 (ja) ヒト造血幹細胞などの血球系細胞を培養するために適した無血清培地および培養方法
JPH06508987A (ja) 造血細胞を支持するシステム及び方法
JP7713233B2 (ja) ヒト造血幹細胞を培養するために適したアルブミンフリーの無血清培地およびアルブミンフリーの培養方法
EP0752867A1 (en) Selective cell proliferation
EP1857542A1 (en) Method for in vitro amplification of adult stem cells
CN115651903B (zh) 高杀伤力的免疫细胞群及其培养方法、试剂组合物和应用
JP5717030B2 (ja) 有核赤血球の脱核方法及び脱核誘導剤
CN112080469B (zh) T1肽在体外促进脐带血造血干细胞增殖中的应用
JP6817633B2 (ja) 造血幹細胞増幅誘導剤
TW202242096A (zh) 用於擴增並維持HSCs自我更新能力和分化潛能的培養基組合物及其應用
CN1310672C (zh) 作为造血刺激物的成骨生长寡肽
WO2025028606A1 (ja) ヒト細胞用培養培地及びヒト造血幹細胞の培養方法
HK40078066A (en) Serum-free medium and culturing method suited for culturing blood cells such as human hematopoietic stem cells
WO2014181783A1 (ja) 赤芽球の脱核方法及び脱核赤血球の維持方法
JP2022017977A (ja) 細胞、組成物及び治療用組成物
JPH11180877A (ja) 巨核球前駆細胞を含む細胞製剤及びその製造方法
Hughes The effect of recombinant bone morphogenetic protein-2 on three populations of hematopoietic cells in cord blood
JP2003289856A (ja) 造血細胞培養用培地

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070119

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20071102

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100521

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20100625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101005

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101022

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101207

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20101214

R150 Certificate of patent or registration of utility model

Ref document number: 4651282

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131224

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees